Clinical Trials 667 Views Cantargia reports encouraging results Malin Otmani March 2, 2022 Cantargia has reported new encouraging …
Clinical Trials 483 Views Cantargia reports treatment of first triple negative breast cancer patient Malin Otmani January 25, 2022 Cantargia has reported treatment of …
Biotech Business 793 Views Cantargia receives positive opinion from EMA (COMP) Malin Otmani October 19, 2021 Cantargia has announced that the …
Clinical Trials 763 Views Cantargia receives approval to start clinical study Malin Otmani September 15, 2021 Cantargia receives regulatory approval to …
Clinical Trials 838 Views Cantargia expands CIRIFOUR trial Malin Otmani August 25, 2021 The company expands the trial …
Clinical Trials 730 Views Cantargia submits clinical trial application Malin Otmani August 5, 2021 Cantargia has announced the submission …
Clinical Trials 833 Views Cantargia broadens the development of nadunolimab Malin Otmani July 12, 2021 Cantargia has announced that the …
Clinical Trials 1091 Views Cantargia announces positive trial results Malin Otmani May 25, 2021 The company has reported positive …
Biotech Business 883 Views Cantargia has completed a directed share issue of approximately SEK 564 million Malin Otmani December 16, 2020 Investors in the Directed Share …
Agreement 1347 Views BioInvent and Cantargia sign manufacturing agreement Malin Otmani December 11, 2020 Cantargia and BioInvent International have …
Clinical Trials 1312 Views Cantargia reports new trial results and presents next development steps Malin Otmani September 24, 2020 Cantargia has announced updated interim …
Pharma Business 985 Views Cantargia’s IND application for CAN04 approved by FDA Malin Otmani May 4, 2020 Cantargia has announced that its …
Intellectual Property 2119 Views Cantargia acquires Cellerant IP on IL1RAP Malin Otmani March 12, 2020 Cantargia has announced the acquisition …
Financing 1094 Views Cantargia completes a directed share issue of approximately 410 million SEK Malin Otmani February 20, 2020 Through the Directed Share Issue, …
Clinical Trials 1321 Views Cantargia selects CAN10 as development project in systemic sclerosis and myocarditis Malin Otmani December 12, 2019 Cantargia has announced that its …
Intellectual Property 1070 Views An opposition has been filed against one of Cantargia’s patents Malin Otmani October 16, 2019 An opposition has been filed …